Liminatus Pharma Inc. Cla... (LIMN)
NASDAQ: LIMN
· Real-Time Price · USD
3.96
-0.04 (-1.00%)
At close: Aug 18, 2025, 3:59 PM
4.03
1.66%
Pre-market: Aug 19, 2025, 07:00 AM EDT
Company Description
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.
The company is based in LA Palma, California.
Liminatus Pharma Inc. Class A Common Stock
| Country | United States |
| IPO Date | May 1, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Chris Kim |
Contact Details
Address: 6 Centerpointe Drive La Palma, California United States | |
| Website | https://liminatuspharma.com |
Stock Details
| Ticker Symbol | LIMN |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001971387 |
| CUSIP Number | |
| ISIN Number | US53271X1081 |
| Employer ID | 00-0000000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chris Kim J.D., L.L.M. | Chief Executive Officer, Treasurer & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 15, 2025 | 3 | Filing |
| Aug 15, 2025 | NT 10-Q | Filing |
| Aug 14, 2025 | 8-K | Current Report |
| Aug 13, 2025 | 424B3 | Filing |
| Jul 23, 2025 | 3 | Filing |
| Jul 21, 2025 | 3 | Filing |
| Jul 17, 2025 | 8-K | Current Report |
| Jul 11, 2025 | 8-K | Current Report |
| Jul 03, 2025 | 8-K | Current Report |
| Jun 27, 2025 | SCHEDULE 13G | Filing |